Bronchial Thermoplasty in Severe Persistent Asthma
Diseases and Conditions Researched
What is the purpose of this trial?
As Conditions of Approval of the PMA for the Alair System, the FDA requires Asthmatx to generate data to assess the durability of the BT treatment effect as well as safety data in the intended use population in the United States.
Click here for detailed participation information for this trial.
|Sponsors:||Asthmatx, Inc.; Boston Scientific Corporation|
|Dates:||April 15, 2011|
|Last Updated:||January 15, 2013|
How will my information be used?
When you express interest in a specific study, the information from your profile will be sent to the doctor conducting that study. If you're eligible to participate, you may be contacted by a nurse or study coordinator.
If you select a health category rather than a specific study, doctors who have active studies in that area may contact you to ask if you would like to participate.
In both cases, you will be contacted by the preferred method (email or phone) that you specified in your profile.